Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Molecular Therapy Oncolytics|January 2, 2023
A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.Cell Reports|June 13, 2025
Vault RNAs aid RNA virus infection by facilitating cytoplasmic localization of hnRNP C and ELAVL1Jorn E Stok, Sander B van der Kooij, Dennis Gravekamp, et al.Orphanet Journal of Rare Diseases|April 25, 2012
Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedureMinke H de Ru, Quirine Ga Teunissen, Johanna H van der Lee, et al.The Journal of Clinical Investigation|January 15, 2019
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I van der Lee, Rogier M Reijmers, Maria W Honders, et al.Blood|March 18, 2015
ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformationMir Farshid Alemdehy, Jurgen R Haanstra, Hans W J de Looper, et al.Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.Frontiers in Immunology|April 7, 2023
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancerRosa A van Amerongen, Sander Tuit, Anne K Wouters, et al.Science Advances|April 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoireHannes Kehm, Stefan Zens, Daniel Baumann, et al.Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.Pageof 11